 | Acasti Pharma, Inc. | |||
| NCM : ACST || Location: Canada | ||||
$2.88+0.03 (+1.05%) |
0.0 M | 2.85 - 2.88 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.001 M |
| March 15, 2024 | 0.007 M |
| Feb. 29, 2024 | 0.023 M |
| Feb. 15, 2024 | 0.011 M |
| Jan. 31, 2024 | 0.024 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.32 | -0.30 | 5.53% |
| 09/30/2023 | -0.11 | -0.19 | -69.34% |
| 03/31/2023 | -0.86 | -3.90 | -355.18% |
| 12/31/2022 | -0.94 | -0.54 | 42.72% |
| 12/31/2021 | -0.49 | -0.68 | -38.48% |
ACST Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 9.399M | Shares Float | 6.295M |
| Short Float | 0.001M | Market Cap | 26.79M |
| Institution ownership | 12.13% | Insider ownership | 16.021% |
| Earnings Date | 06/21/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.68 | Forward EPS | -1.10 |